Search clinical trials for: Vemurafenib and Cobimetinib
Total 270403 results
-
Genentech, Inc.Completed
-
ABM Therapeutics CorporationActive, not recruitingAdvanced Solid Tumor | BRAF V600 MutationUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedDisease or R Group HistiocytosesFrance
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Hoffmann-La RocheCompletedLeukemia, Myeloid, AcuteUnited States, Canada, France, Italy
-
Niharika MettuRoche-GenentechWithdrawnMetastatic Colorectal CancerUnited States
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Paola QueiroloIstituto Nazionale per lo Studio e la Cura dei TumoriCompletedMalignant Melanoma Stage IVItaly
-
Genentech, Inc.Terminated
-
Astellas Pharma China, Inc.Terminated
-
Duke UniversityWithdrawn
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Ostfold Hospital... and other collaboratorsRecruitingCancer MetastaticNorway
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
Children's Hospital Medical Center, CincinnatiAstellas Pharma IncCompleted
-
PfizerActive, not recruitingMelanomaCanada, United States, Spain, Germany, Korea, Republic of, Australia, Czechia, Netherlands, France, Hungary, United Kingdom, Switzerland, Singapore, Russian Federation, Italy, Japan, Israel, Brazil, Portugal, Mexico, Greece, Argen... and more
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedMetastatic Colorectal CancerUnited States
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
Hanmi Pharmaceutical Company LimitedActive, not recruitingMetastatic Solid Tumor | Locally Advanced Solid TumorKorea, Republic of
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterRecruiting
-
Scripps HealthRecruiting
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
German Cancer Research CenterRecruiting
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Anna RaciborskaMaria Sklodowska-Curie National Research Institute of Oncology; Łukasiewicz... and other collaboratorsRecruiting
-
Hoffmann-La RocheCompleted
-
SanofiCompletedNeoplasm MalignantCanada, United States
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Shanghai Kechow Pharma, Inc.Recruiting
-
HonorHealth Research InstituteBayer; Genentech, Inc.Recruiting
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Hungary, Spain, Korea, Republic of, United Kingdom, United States, Croatia, Greece, Portugal, Germany, Bosnia and Herzegovina, Belgium, South Africa, Israel, Romania, New Zealand, Italy, Canada, Netherlands, Egypt, Russian... and more
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.RecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsCanada